Haofei Xiong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Haofei Xiong has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Lili Wei
State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China
4 shared publications- Bin Peng
The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan, China
2 shared publications Bo Li
Associate Professor and Head, Department of Oral Radiology, State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and the Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China
2 shared publicationsL. Wei
The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan, China
2 shared publicationsMingwen Liu
The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan, China
2 shared publicationsWei Li
Senior Registrar, Department of Oral Radiology, State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and the Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China
2 shared publications
Latest Publications
- 2 June 2020
- Published by Wiley in Oral Diseases
- Vol. 27 (6) , 1356-1365
An update of knowledge on the regulatory role of Treg cells in apical periodontitis
Apical periodontitis (AP) is a prevalent infectious and inflammatory disorder that involves inflammation of periapical tissues and the disintegration of alveolar bone. AP may eventually lead to tooth loss if not timely treated. This disease is caused by pathogenic bacteria in the necrotic pulps and root canals, thereby triggering responses from the innate and adaptive immune system of the periapical tissues. Regulatory T (Treg) cells play a major role in maintaining immune homoeostasis and immunological self‐tolerance; however, these only account for roughly 5%–10% of human peripheral CD4+ T cells. Several studies have examined the possible role and underlying mechanism of Treg cells in different inflammatory and autoimmune disorders to facilitate the development of novel treatments for these diseases. Recent studies have indicated that Treg cells may gather at the sites of infection, thus limiting the generation of immune responses and bone resorption in the periapical area. This review will summarize studies regarding the presence and regulatory role of Treg cells in AP.
- 2 June 2020
- Published by Wiley in Oral Diseases
- Vol. 27 (6) , 1356-1365
An update of knowledge on the regulatory role of Treg cells in apical periodontitis
Apical periodontitis (AP) is a prevalent infectious and inflammatory disorder that involves inflammation of periapical tissues and the disintegration of alveolar bone. AP may eventually lead to tooth loss if not timely treated. This disease is caused by pathogenic bacteria in the necrotic pulps and root canals, thereby triggering responses from the innate and adaptive immune system of the periapical tissues. Regulatory T (Treg) cells play a major role in maintaining immune homoeostasis and immunological self‐tolerance; however, these only account for roughly 5%–10% of human peripheral CD4+ T cells. Several studies have examined the possible role and underlying mechanism of Treg cells in different inflammatory and autoimmune disorders to facilitate the development of novel treatments for these diseases. Recent studies have indicated that Treg cells may gather at the sites of infection, thus limiting the generation of immune responses and bone resorption in the periapical area. This review will summarize studies regarding the presence and regulatory role of Treg cells in AP.
- Open Access
- 21 August 2019
- Published by Wiley in Mediators of Inflammation
- Vol. 2019, 1-10
Role of Calprotectin as a Biomarker in Periodontal Disease
Periodontal disease (PD) is a common infectious and inflammatory disease characterised by inflammation of tissues surrounding and supporting the teeth and destruction of the associated alveolar bone, eventually resulting in tooth loss. This disease is caused by periodontopathic bacteria in plaque biofilm and resultant innate and adaptive immune responses in periodontal tissues. Calprotectin (CLP) is a calcium-binding protein of the S-100 protein family and is found to be induced by activated granulocytes, monocytes, and epithelial cells. CLP has been shown to play an important role in numerous inflammatory diseases and disorders. Increasing evidence indicates that CLP is involved in the progression of PD, and its levels may be associated with disease severity and outcome of periodontal treatments. This review will summarise recent studies regarding the presence, regulation, and function of CLP in PD. The findings indicate that CLP may be an effective biomarker for diagnosis and treatment for the PD.
- 21 August 2019
- Published by Wiley in Mediators of Inflammation
- Vol. 2019, 1-10
Open AccessRole of Calprotectin as a Biomarker in Periodontal Disease
Periodontal disease (PD) is a common infectious and inflammatory disease characterised by inflammation of tissues surrounding and supporting the teeth and destruction of the associated alveolar bone, eventually resulting in tooth loss. This disease is caused by periodontopathic bacteria in plaque biofilm and resultant innate and adaptive immune responses in periodontal tissues. Calprotectin (CLP) is a calcium-binding protein of the S-100 protein family and is found to be induced by activated granulocytes, monocytes, and epithelial cells. CLP has been shown to play an important role in numerous inflammatory diseases and disorders. Increasing evidence indicates that CLP is involved in the progression of PD, and its levels may be associated with disease severity and outcome of periodontal treatments. This review will summarise recent studies regarding the presence, regulation, and function of CLP in PD. The findings indicate that CLP may be an effective biomarker for diagnosis and treatment for the PD.
- Open Access
- 12 March 2019
- Published by Wiley in International Endodontic Journal
- Vol. 52 (8) , 1128-1137
The Presence and involvement of interleukin‐17 in apical periodontitis
Apical periodontitis (AP) is a chronic inflammatory disease characterized by periapical tissue inflammation and destruction of the associated alveolar bone. It is caused by microbial infections within the root canal and the resultant host immune responses in the periapical tissues. The proinflammatory cytokine interleukin (IL)‐17 has been shown to play an important role in many inflammatory diseases. There is increasing evidence of the presence of IL‐17 in AP, which might be associated with disease pathogenesis. Moreover, several animal studies indicate the potential role of IL‐17 in periapical inflammation and the resultant bone resorption in AP. This article reviews recent studies regarding the collective in vitro, in vivo and clinical evidence of the presence and involvement of IL‐17 in AP. A search related to IL‐17 in apical periodontitis was conducted on PubMed, EMBASE and Web of Science databases using keywords and controlled vocabulary. Two independent reviewers first screened titles and abstracts and then the full texts that were included. A total of 25 papers were identified, of the 25 included articles, 7 involved laboratory studies on cell cultures, 11 involved animal experimentations, and 7 were observational studies using human clinical samples. In conclusion, evidence for the presence of IL‐17 in AP from human and animal models is clear. However, there is relatively little information currently available that would highlight the specific role of IL‐17 in AP.
- 12 March 2019
- Published by Wiley in International Endodontic Journal
- Vol. 52 (8) , 1128-1137
Open AccessThe Presence and involvement of interleukin‐17 in apical periodontitis
Apical periodontitis (AP) is a chronic inflammatory disease characterized by periapical tissue inflammation and destruction of the associated alveolar bone. It is caused by microbial infections within the root canal and the resultant host immune responses in the periapical tissues. The proinflammatory cytokine interleukin (IL)‐17 has been shown to play an important role in many inflammatory diseases. There is increasing evidence of the presence of IL‐17 in AP, which might be associated with disease pathogenesis. Moreover, several animal studies indicate the potential role of IL‐17 in periapical inflammation and the resultant bone resorption in AP. This article reviews recent studies regarding the collective in vitro, in vivo and clinical evidence of the presence and involvement of IL‐17 in AP. A search related to IL‐17 in apical periodontitis was conducted on PubMed, EMBASE and Web of Science databases using keywords and controlled vocabulary. Two independent reviewers first screened titles and abstracts and then the full texts that were included. A total of 25 papers were identified, of the 25 included articles, 7 involved laboratory studies on cell cultures, 11 involved animal experimentations, and 7 were observational studies using human clinical samples. In conclusion, evidence for the presence of IL‐17 in AP from human and animal models is clear. However, there is relatively little information currently available that would highlight the specific role of IL‐17 in AP.
- 1 March 2019
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 77 (3) , 493-498
Leptin Levels in the Synovial Fluid of Patients With Temporomandibular Disorders
- 1 March 2019
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 77 (3) , 493-498
Leptin Levels in the Synovial Fluid of Patients With Temporomandibular Disorders
- 2 January 2019
- Published by Medical Journals Sweden AB in Acta Odontologica Scandinavica
- Vol. 77 (3) , 205-212
Leptin induces IL-6 and IL-8 expression through leptin receptor Ob-Rb in human dental pulp fibroblasts
Objective: Leptin, through binding to its special receptor (Ob-Rb), has potent effects on immunity and inflammation. This study aimed to investigate the expression of leptin receptor Ob-Rb in human dental pulp fibroblasts (HDPFs) and the effects of leptin on the production of proinflammatory cytokines of IL-6 and IL-8 by HDPFs. Methods: Ob-Rb expression was determined by quantitative real-time PCR (real-time PCR), Western blot and immunofluorescence analyses in cultured HDPFs. Small interfering RNA (siRNA) was transfected into HDPFs to down-regulate the expression of Ob-Rb. Real-time PCR and enzyme-linked immunosorbent assay (ELISA) were used to determine the proinflammatory cytokines of IL-6 and IL-8 levels in leptin-stimulated HDPFs. The involved signalling pathways that mediate the leptin-stimulated production of proinflammatory cytokines were investigated using Western blot and specific signalling inhibitor analyses. Results: The expression levels of Ob-Rb mRNA and protein were detected in HDPFs. Leptin could stimulate mRNA and protein expression of IL-6 and IL-8 in HDPFs in a concentration-dependent and time-dependent manner. Transfection with siRNA targeting Ob-Rb resulted in remarkable reduction of IL-6 and IL-8 expressions by HDPFs. In accordance with the enhanced expression of proinflammatory cytokines, leptin stimulation resulted in rapid phosphorylation of STAT3, p38 MAPK, ERK and Akt in HDPFs. Inhibiting JAK2/STAT3, p38 MAPK or PI3K/Akt substantially decreased leptin-induced IL-6 production, whereas blocking ERK and p38 MAPK substantially suppressed IL-8 production from leptin-stimulated HDPFs. Conclusions: Leptin may up-regulate IL-6 and IL-8 production through binding with Ob-Rb in HDPFs via the activation of different intracellular signalling pathways.
- 2 January 2019
- Published by Medical Journals Sweden AB in Acta Odontologica Scandinavica
- Vol. 77 (3) , 205-212
Leptin induces IL-6 and IL-8 expression through leptin receptor Ob-Rb in human dental pulp fibroblasts
Objective: Leptin, through binding to its special receptor (Ob-Rb), has potent effects on immunity and inflammation. This study aimed to investigate the expression of leptin receptor Ob-Rb in human dental pulp fibroblasts (HDPFs) and the effects of leptin on the production of proinflammatory cytokines of IL-6 and IL-8 by HDPFs. Methods: Ob-Rb expression was determined by quantitative real-time PCR (real-time PCR), Western blot and immunofluorescence analyses in cultured HDPFs. Small interfering RNA (siRNA) was transfected into HDPFs to down-regulate the expression of Ob-Rb. Real-time PCR and enzyme-linked immunosorbent assay (ELISA) were used to determine the proinflammatory cytokines of IL-6 and IL-8 levels in leptin-stimulated HDPFs. The involved signalling pathways that mediate the leptin-stimulated production of proinflammatory cytokines were investigated using Western blot and specific signalling inhibitor analyses. Results: The expression levels of Ob-Rb mRNA and protein were detected in HDPFs. Leptin could stimulate mRNA and protein expression of IL-6 and IL-8 in HDPFs in a concentration-dependent and time-dependent manner. Transfection with siRNA targeting Ob-Rb resulted in remarkable reduction of IL-6 and IL-8 expressions by HDPFs. In accordance with the enhanced expression of proinflammatory cytokines, leptin stimulation resulted in rapid phosphorylation of STAT3, p38 MAPK, ERK and Akt in HDPFs. Inhibiting JAK2/STAT3, p38 MAPK or PI3K/Akt substantially decreased leptin-induced IL-6 production, whereas blocking ERK and p38 MAPK substantially suppressed IL-8 production from leptin-stimulated HDPFs. Conclusions: Leptin may up-regulate IL-6 and IL-8 production through binding with Ob-Rb in HDPFs via the activation of different intracellular signalling pathways.
- 14 July 2018
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 47 (9) , 847-855
Upregulation of IL‐6 expression in human salivary gland cell line by IL‐17 via activation of p38 MAPK, ERK, PI3K/Akt, and NF‐κB pathways
Background The human salivary gland cell line (HSG) has so far been used as in vitro models for study of the influence of cytokines and pharmacologic agents on salivary glands, as well as a model system for inflammation in Sjögren's syndrome (SS). This study aimed to determine the effect of IL‐17 on IL‐6 production and the underlying molecular mechanism regulated by the HSG cell line. Methods Immunofluorescence analyses, RT‐PCR, and Western blot were conducted to evaluate the IL‐17 receptor (IL‐17R) expression in cultured HSG cells. Real‐time PCR and ELISA were then utilized to establish the mRNA and protein levels of IL‐6 in IL‐17‐stimulated HSG cells. Western blot, flow cytometry, immunofluorescence and inhibitor analyses were conducted to elucidate the involved signaling pathways. Results The HSG cells reliably expressed the IL‐17R mRNA and its encoded surface‐bound protein. The expression of IL‐6 mRNA and protein was upregulated by stimulation of HSG cells with IL‐17; this effect was impeded by IL‐17 or IL‐17R‐neutralizing antibodies. IL‐17 stimulation ended up with the fast phosphorylation of p38 mitogen‐activated protein kinase (MAPK), extracellular signal‐regulated kinase (ERK), Akt, and translocation of nuclear factor‐kappaB (NF‐κB) in the HSG cells. p38 MAPK, Akt, and NF‐κB inhibitors significantly subdued IL‐6 generation in HSG cells stimulated by IL‐17. PD98059, an ERK inhibitor, decreased IL‐6 generation under low‐dose of IL‐17 but not with high‐dose. Conclusions The HSG cells expressed IL‐17R and reacted to IL‐17 to generate IL‐6 via the stimulation of ERK, p38 MAPK, Akt, and NF‐κB signaling pathways.
- 14 July 2018
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 47 (9) , 847-855
Upregulation of IL‐6 expression in human salivary gland cell line by IL‐17 via activation of p38 MAPK, ERK, PI3K/Akt, and NF‐κB pathways
Background The human salivary gland cell line (HSG) has so far been used as in vitro models for study of the influence of cytokines and pharmacologic agents on salivary glands, as well as a model system for inflammation in Sjögren's syndrome (SS). This study aimed to determine the effect of IL‐17 on IL‐6 production and the underlying molecular mechanism regulated by the HSG cell line. Methods Immunofluorescence analyses, RT‐PCR, and Western blot were conducted to evaluate the IL‐17 receptor (IL‐17R) expression in cultured HSG cells. Real‐time PCR and ELISA were then utilized to establish the mRNA and protein levels of IL‐6 in IL‐17‐stimulated HSG cells. Western blot, flow cytometry, immunofluorescence and inhibitor analyses were conducted to elucidate the involved signaling pathways. Results The HSG cells reliably expressed the IL‐17R mRNA and its encoded surface‐bound protein. The expression of IL‐6 mRNA and protein was upregulated by stimulation of HSG cells with IL‐17; this effect was impeded by IL‐17 or IL‐17R‐neutralizing antibodies. IL‐17 stimulation ended up with the fast phosphorylation of p38 mitogen‐activated protein kinase (MAPK), extracellular signal‐regulated kinase (ERK), Akt, and translocation of nuclear factor‐kappaB (NF‐κB) in the HSG cells. p38 MAPK, Akt, and NF‐κB inhibitors significantly subdued IL‐6 generation in HSG cells stimulated by IL‐17. PD98059, an ERK inhibitor, decreased IL‐6 generation under low‐dose of IL‐17 but not with high‐dose. Conclusions The HSG cells expressed IL‐17R and reacted to IL‐17 to generate IL‐6 via the stimulation of ERK, p38 MAPK, Akt, and NF‐κB signaling pathways.
- 6 November 2017
- Published by Wiley in International Endodontic Journal
- Vol. 51 (6) , 622-631
Up‐regulation of IL‐23 expression in human dental pulp fibroblasts by IL‐17 via activation of the NF‐κB and MAPK pathways
Aim: To investigate the effects of the pro‐inflammatory and Th17‐polarizing mediator IL‐17 on HDPFs‐mediated IL‐23 production and the molecular mechanism involved.Methodology: Interleukin (IL)‐17R expression was determined by semi‐quantitative reverse transcriptase‐polymerase chain reaction and Western blot in cultured human dental pulp fibroblasts (HDPFs). Quantitative real‐time polymerase chain reaction and enzyme‐linked immunosorbent assay were used to determine IL‐23 mRNA and protein levels in IL‐17‐stimulated HDPFs, respectively. The nuclear factor‐kappa B (NF‐κB) and mitogen‐activated protein kinases (MAPKs) signalling pathways that mediate the IL‐17‐stimulated production of IL‐23 was investigated using Western blot and specific signalling inhibitor analyses. Statistical analyses were performed using Kruskal–Wallis tests followed by the Mann–Whitney U‐test. Statistical significance was considered when the P value < 0.05.Results: Primary HDPFs steadily expressed IL‐17R mRNA and surface‐bound protein. IL‐17 stimulated the expression of IL‐23 mRNA and protein in cultured human dental pulp fibroblasts, which was attenuated by IL‐17 or IL‐17R neutralizing antibodies. In accordance with the enhanced expression of IL‐23, IL‐17 stimulation resulted in rapid activation of p38 MAPK, extracellular signal‐regulated kinase (ERK) 1/2, c‐Jun‐N‐terminal kinase (JNK) and NF‐κB in HDPFs. Inhibitors of p38 MAPK, ERK 1/2 or NF‐κB significantly suppressed, whereas blocking JNK substantially augmented IL‐23 production from IL‐17‐stimulated HDPFs.Conclusion: HDPFs expressed IL‐17R and responded to IL‐17 to produce IL‐23 via the activation of the NF‐κB and MAPK signalling pathways. The findings provide insights into the cellular mechanisms of the participation of IL‐17 in the activation of HDPFs in inflamed pulp tissue.
- 6 November 2017
- Published by Wiley in International Endodontic Journal
- Vol. 51 (6) , 622-631
Up‐regulation of IL‐23 expression in human dental pulp fibroblasts by IL‐17 via activation of the NF‐κB and MAPK pathways
Aim: To investigate the effects of the pro‐inflammatory and Th17‐polarizing mediator IL‐17 on HDPFs‐mediated IL‐23 production and the molecular mechanism involved.Methodology: Interleukin (IL)‐17R expression was determined by semi‐quantitative reverse transcriptase‐polymerase chain reaction and Western blot in cultured human dental pulp fibroblasts (HDPFs). Quantitative real‐time polymerase chain reaction and enzyme‐linked immunosorbent assay were used to determine IL‐23 mRNA and protein levels in IL‐17‐stimulated HDPFs, respectively. The nuclear factor‐kappa B (NF‐κB) and mitogen‐activated protein kinases (MAPKs) signalling pathways that mediate the IL‐17‐stimulated production of IL‐23 was investigated using Western blot and specific signalling inhibitor analyses. Statistical analyses were performed using Kruskal–Wallis tests followed by the Mann–Whitney U‐test. Statistical significance was considered when the P value < 0.05.Results: Primary HDPFs steadily expressed IL‐17R mRNA and surface‐bound protein. IL‐17 stimulated the expression of IL‐23 mRNA and protein in cultured human dental pulp fibroblasts, which was attenuated by IL‐17 or IL‐17R neutralizing antibodies. In accordance with the enhanced expression of IL‐23, IL‐17 stimulation resulted in rapid activation of p38 MAPK, extracellular signal‐regulated kinase (ERK) 1/2, c‐Jun‐N‐terminal kinase (JNK) and NF‐κB in HDPFs. Inhibitors of p38 MAPK, ERK 1/2 or NF‐κB significantly suppressed, whereas blocking JNK substantially augmented IL‐23 production from IL‐17‐stimulated HDPFs.Conclusion: HDPFs expressed IL‐17R and responded to IL‐17 to produce IL‐23 via the activation of the NF‐κB and MAPK signalling pathways. The findings provide insights into the cellular mechanisms of the participation of IL‐17 in the activation of HDPFs in inflamed pulp tissue.